Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

It is uncertain, given the lack of recent data and the inconclusive nature of previous data, whether ethambutol is cleared by hemodialysis using contemporary dialyzers. We measured serum ethambutol concentrations before, during, and 1 h after hemodialysis in a 75-year-old Caucasian man receiving ethambutol for disseminated Bacille Calmette-Guérin infection. There was a mean 41% decrease in serum ethambutol concentration during dialysis, confirming the hemodialyzability of ethambutol and the utility of drug monitoring in ensuring safety.

Original publication

DOI

10.1128/aac.01988-16

Type

Journal article

Journal

Antimicrobial agents and chemotherapy

Publication Date

06/2017

Volume

61

Pages

e01988 - e01916

Addresses

Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, Australia christopher.chew@doctors.org.uk marion.woods@health.qld.gov.au.

Keywords

Humans, Ethambutol, Drug Monitoring, Renal Dialysis, Aged, Male